Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?

J Hepatol. 2021 Jul;75(1):222-224. doi: 10.1016/j.jhep.2021.04.003. Epub 2021 Apr 20.

Authors

Fernando Bril¹, Sameer Al Diffalha², Mark Dean³, David M Fettig⁴

Affiliations

¹ Internal Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: fbril@uab.edu.
² Division of Anatomic Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
³ Internal Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
⁴ Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

No abstract available

Keywords: SARS-CoV-2; coronavirus; liver injury; mRNA vaccines.

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Antinuclear / blood*
BNT162 Vaccine
Biopsy / methods
COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 Vaccines* / administration & dosage
COVID-19 Vaccines* / adverse effects
DNA / immunology
Endosonography / methods
Female
Glucocorticoids / administration & dosage
Hepatitis, Autoimmune* / diagnosis
Hepatitis, Autoimmune* / immunology
Hepatitis, Autoimmune* / physiopathology
Hepatitis, Autoimmune* / therapy
Humans
Liver Function Tests / methods
Liver* / diagnostic imaging
Liver* / pathology
Postpartum Period
Prednisone / administration & dosage*
SARS-CoV-2
Treatment Outcome

Substances

Antibodies, Antinuclear
COVID-19 Vaccines
Glucocorticoids
DNA
BNT162 Vaccine
Prednisone